In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values

BACKGROUND: At present, the clinical breakpoints (CBPs) of both fluconazole and voriconazole are available only for 3 common Candida species in the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) methods. Epidemiological...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Min Joong, Shin, Jong Hee, Lee, Wee Gyo, Kim, Mi-Na, Lee, Kyungwon, Lee, Hye Soo, Lee, Mi-Kyung, Chang, Chulhun L., Jang, Hee-Chang, Song, Eun Song, Kim, Soo Hyun, Shin, Myung-Geun, Suh, Soon-Pal, Ryang, Dong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646190/
https://www.ncbi.nlm.nih.gov/pubmed/23667842
http://dx.doi.org/10.3343/alm.2013.33.3.167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646190/
https://www.ncbi.nlm.nih.gov/pubmed/23667842
http://dx.doi.org/10.3343/alm.2013.33.3.167

Ejemplares similares